Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.64 MXN
1.08 B MXN
16.47 B MXN
690.36 M
About GENOMMA LAB INTERNACIONAL SAB
Sector
CEO
Marco Sparvieri
Headquarters
Mexico City
Website
Founded
1996
ISIN
MX01LA010006
FIGI
BBG00JX0PJG5
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LAB/B is 26.33 MXN — it has increased by 0.53% in the past 24 hours. Watch GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stocks are traded under the ticker LAB/B.
LAB/B stock has fallen by −1.97% compared to the previous week, the month change is a 7.56% rise, over the last year GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V has showed a 79.48% increase.
We've gathered analysts' opinions on GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V future price: according to them, LAB/B price has a max estimate of 33.00 MXN and a min estimate of 18.00 MXN. Watch LAB/B chart and read a more detailed GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stock forecast: see what analysts think of GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V and suggest that you do with its stocks.
LAB/B stock is 2.35% volatile and has beta coefficient of 0.81. Track GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stock price on the chart and check out the list of the most volatile stocks — is GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V there?
Today GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V has the market capitalization of 26.67 B, it has decreased by −1.80% over the last week.
Yes, you can track GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V financials in yearly and quarterly reports right on TradingView.
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
LAB/B earnings for the last quarter are 0.66 MXN per share, whereas the estimation was 0.54 MXN resulting in a 22.22% surprise. The estimated earnings for the next quarter are 0.38 MXN per share. See more details about GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V earnings.
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V revenue for the last quarter amounts to 5.09 B MXN, despite the estimated figure of 4.66 B MXN. In the next quarter, revenue is expected to reach 3.95 B MXN.
LAB/B net income for the last quarter is 660.06 M MXN, while the quarter before that showed 631.64 M MXN of net income which accounts for 4.50% change. Track more GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V financial stats to get the full picture.
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V dividend yield was 5.57% in 2023, and payout ratio reached 69.55%. The year before the numbers were 3.41% and 41.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 23, 2024, the company has 1.59 K employees. See our rating of the largest employees — is GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V EBITDA is 4.00 B MXN, and current EBITDA margin is 21.13%. See more stats in GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V financial statements.
Like other stocks, LAB/B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stock shows the buy signal. See more of GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.